Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 4, 2026 · Multiple disclosures including restructuring or layoffs and material agreement
Syndax Pharmaceuticals Inc
8
Restructuring or layoffs
Jun 4, 2026
| ItemItem | Disclosure |
|---|---|
| Item 1.01 | Entered a material definitive agreement |
| Item 2.03 | Created a direct financial obligation |
| Item 2.05 | Recorded exit or disposal costs (restructuring, layoffs, closures) |
| Item 3.02 | Item 3.02 |
| Item 8.01 | Other events the company considers material |
| Item 9.01 | Financial statements and exhibits |
Syndax Pharmaceuticals Inc filed this because it recorded material costs from a restructuring, layoff, facility closure, or similar exit activity that investors must be told about promptly.
1 Syndax Announces Private Placement of $250. 0 Million of Convertible Senior Notes NEW YORK, June 4, 2026 — Syndax Pharmaceuticals, Inc.
This filing reports Item 1.01 (entered a material definitive agreement); Item 2.05 (recorded exit or disposal costs (restructuring, layoffs, closures)); Item 8.01 (other events the company considers material). These item codes often precede or accompany restructuring, leadership changes, or deals that can shift headcount.
Syndax Pharmaceuticals Inc reported material events that can affect workforce planning. cutoffs surfaces the filing alongside WARN layoffs, H-1B activity, and company signals.
